Animal protocols were conducted in accordance with guidelines set forth by the Cincinnati Children's Hospital Medical Center Institutional Animal Care and Use Committee and the National Institutes of Health. All mice used in this study were maintained on an outbred background. Dlx1-Cre mice (RRID:MMRRC_036076-UCD) were obtained from GENSAT (Gong et al., 2007; Gerfen et al., 2013) and were genotyped with the following primers: Dlx1-Cre5 (5′-ATGCAAGAGAGCCGACCAAT-3′) and Dlx1-Cre3 (5′-GGCAAACGGACAGAAGCATT-3′). Sp8-GFP BAC (RRID:MMRRC_034608-UCD) mice were obtained from GENSAT (Gong et al., 2003) and genotyped with the primers GFP57-5′ (5′-AGCAAAGACCCCAACGAGAAGC-3′) and GFP57-3′ (5′-CCAACAACAGATGGCTGGCAAC-3′). Tshz1GFP mice (Ragancokova et al., 2014) were genotyped with either of the following two primer pairs: Tshz1GFP5 (5′-GTTGAGGTGGCCTTGTAAGC-3′) and Tshz1GFP-GFP3 (5′-AAGTCGTGCTGCTTCATGTG-3′) or EGFP5 (5′-GACGTAAACGGCCACAAGTTC) and EGFP3 (5′-CTTCAGCTCGATGCGGTTCA-3′). The Tshz1Flox allele (Ragancokova et al., 2014) was genotyped with the following primers: Tshz1RA5 (ATCAGGGGTCTTGGTGTCCT) and Tshz1RA-WT3 (5′-AGTTCAGTCCTTCCGTGGTG-3′). The Tshz1Flox mice were crossed with EIIa-cre mice (The Jackson Laboratory; RRID:IMSR_JAX:003724) to generate the recombined null allele Tshz1RA and genotyped with the following primers: Tshz1RA5 (5′-ATCAGGGGTCTTGGTGTCCT-3′) and Tshz1RA-RA3 (5′-TCCCCACAGCCTCTAACCATA-3′). The Tshz1WT allele was genotyped with the primer set: Tshz1GFP5: (5′-GTTGAGGTGGCCTTGTAAGC-3′) and Tshz1GFP-WT3 (5′-ATTCGCTCTCCTGAATGTCC-3′). The Gsx2RA allele (RRID:MGI:4412087) (Waclaw et al., 2009) was genotyped with the primers: Gsx2RA5: (5′-ACGGAGATTCCACTGCCTCT-3′) and Gsx2RA3 (5′-CTCCCAGACACAGATCCAGAC-3′). The Gsx2WT allele was genotyped with the primers Gsx2–1437 (5′-GCATCCACCCCAAATCTCAGTC-3′) and Gsx2-Int5b (5′-CCACGGAGATTCCACTGCC-3′). Foxp2S321X mice (RRID:MGI:3795717) were genotyped as described previously (Gaub et al., 2010).
For staging of embryos, the day of vaginal plug detection was considered embryonic day 0.5 (E0.5). Brains were collected at the time point indicated in the figures. Brains of embryos E15.5 and older were dissected from the skull before fixation, whereas brains of embryos E14.5 and younger were fixed with the forming skull intact. Tissues were fixed in 4% PFA overnight. Brains at P3 and younger were cryoprotected in 30% sucrose, and 12 μm sections were collected with a cryostat and stored at −20°C. Brains that were P12 and older were cryoprotected in 12% sucrose and sectioned on a sliding microtome at 35 μm. Sections were stored at −20°C in a solution of 30% glycerol/30% ethylene glycol in PBS.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.